SCHEMBL21908246

SCHEMBL21908246

CNC(=O)C1=CN(CC(F)CCn2cc(C=O)nn2)NN1

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GLS O94925 20/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21907449 0.77 GLS (0.74) GLS
SCHEMBL21907452 0.72 GLS (0.78) GLS
SCHEMBL21907921 0.72 GLS (0.39) GLS
SCHEMBL21907722 0.72 GLS (0.77) GLS
SCHEMBL21908252 0.71 GLS (0.59) GLS
SCHEMBL17411861 0.70 GLS (0.58) GLS
SCHEMBL17411580 0.69 — —
SCHEMBL21907597 0.69 GLS (0.62) GLS
SCHEMBL17411590 0.65 GLS (0.78) GLS
SCHEMBL21907453 0.65 GLS (0.69) GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3677579-A1 HETEROCYCLIC GLS1 INHIBITORS Board of Regents, The University of Texas System (US) 2020-07-08 — — EP disclosed
EP-3164394-B1 GLS1 INHIBITORS FOR TREATING DISEASES UNIV TEXAS (US) 2020-04-01 — — EP disclosed
Send feedback